In this tumor, both DRD2 agonists were effective in reducing PRL secretion in the cell culture media (cabergoline: −46.14 ± 1.2%; UNC9994: −33.7 ± 0.57%; both p < 0.001 vs. bas) (Figure 2b). The gene discussed is DRD2; the disease is neoplasm.